Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 9,775,844

Try a free trial See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,775,844

Title:	Heterocyclic compounds and uses thereof
Abstract:	Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
Inventor(s):	Kutok; Jeffery L. (Natick, MA), Winkler; David G. (Arlington, MA), Palombella; Vito J. (Needham, MA), Castro; Alfredo C. (Woburn, MA), Evans; Catherine A. (Somerville, MA), Janardanannair; Somarajannair (Woburn, MA), Lescarbeau; Andre (Somerville, MA), Liu; Tao (Wellesley, MA), Tremblay; Martin R. (Melrose, MA)
Assignee:	Infinity Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:	14/661,656
Patent Claims:	see list of patent claims

Details for Patent 9,775,844

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125554	001	2015-11-23	➤ Sign Up	Infinity Pharmaceuticals, Inc. (Cambridge, MA)	➤ Sign Up	RX	Orphan	search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	002	2015-03-04	➤ Sign Up	Infinity Pharmaceuticals, Inc. (Cambridge, MA)	➤ Sign Up	RX		search
Bristol Myers Squibb	OPDIVO	nivolumab	INJECTABLE;INJECTION	125527	001	2015-03-04	➤ Sign Up	Infinity Pharmaceuticals, Inc. (Cambridge, MA)	➤ Sign Up	RX		search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up	Infinity Pharmaceuticals, Inc. (Cambridge, MA)	➤ Sign Up	RX	Orphan	search
Bristol Myers Squibb	YERVOY	ipilimumab	INJECTABLE; INJECTION	125377	001	2011-03-25	➤ Sign Up	Infinity Pharmaceuticals, Inc. (Cambridge, MA)	➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patent Family for US Patent 9,775,844

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	2015143012	Sep 24, 2015
United States of America	2015290207	Oct 15, 2015
United States of America	2018055852	Mar 01, 2018
Singapore	10201808053X	Oct 30, 2018
Singapore	11201607705X	Oct 28, 2016
Philippines	12016501809	Nov 21, 2016
Mexico	2016012021	Apr 13, 2017
Country	Patent Number	Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.